Metastatic skin squamous cell carcinoma
Clinical trials for Metastatic skin squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic skin squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Metastatic skin squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy before surgery tested against aggressive skin cancer
Cure OngoingResearchers are testing whether giving the immunotherapy drug cemiplimab before and after surgery can help patients with high-risk cutaneous squamous cell carcinoma, a type of skin cancer. The trial enrolls people whose cancer has features that raise the risk of it coming back, s…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase 1 • Sponsor: Emory University • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
New hope for immunocompromised skin cancer patients: amivantamab combo tested
Disease control PausedThis phase II trial tests whether a combination of amivantamab and hyaluronidase works as well as cetuximab for treating skin squamous cell carcinoma that has come back or spread. The study enrolls 86 immunocompromised participants, including organ transplant recipients. The goal…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney
Disease control OngoingThis early-stage study tests whether a mix of three drugs—tacrolimus, nivolumab, and ipilimumab—can shrink or control certain skin cancers in people who have had a kidney transplant. The main goal is to see if the cancer responds without causing the body to reject the transplante…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC